NO20020369L - Sammensetninger for forebyggelse og behandling av nyredysfunksjoner og -sykdommer - Google Patents

Sammensetninger for forebyggelse og behandling av nyredysfunksjoner og -sykdommer

Info

Publication number
NO20020369L
NO20020369L NO20020369A NO20020369A NO20020369L NO 20020369 L NO20020369 L NO 20020369L NO 20020369 A NO20020369 A NO 20020369A NO 20020369 A NO20020369 A NO 20020369A NO 20020369 L NO20020369 L NO 20020369L
Authority
NO
Norway
Prior art keywords
diseases
prevention
compositions
treatment
kidney dysfunction
Prior art date
Application number
NO20020369A
Other languages
English (en)
Norwegian (no)
Other versions
NO20020369D0 (no
Inventor
Claudio Cavazza
Original Assignee
Sigma Tau Healthscience Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Healthscience Spa filed Critical Sigma Tau Healthscience Spa
Publication of NO20020369D0 publication Critical patent/NO20020369D0/no
Publication of NO20020369L publication Critical patent/NO20020369L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
NO20020369A 1999-07-28 2002-01-23 Sammensetninger for forebyggelse og behandling av nyredysfunksjoner og -sykdommer NO20020369L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999RM000483A IT1306179B1 (it) 1999-07-28 1999-07-28 Composizione per la prevenzione e cura delle disfunzioni e patologierenali di tipo tossico e funzionale.
PCT/IT2000/000313 WO2001007039A2 (en) 1999-07-28 2000-07-25 L-acetylcarnitine and l-propionylcarnitine containing composition for the prevention and treatment of kidney dysfunctions and diseases

Publications (2)

Publication Number Publication Date
NO20020369D0 NO20020369D0 (no) 2002-01-23
NO20020369L true NO20020369L (no) 2002-03-21

Family

ID=11406910

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020369A NO20020369L (no) 1999-07-28 2002-01-23 Sammensetninger for forebyggelse og behandling av nyredysfunksjoner og -sykdommer

Country Status (20)

Country Link
US (2) US6653349B1 (es)
EP (1) EP1200077B1 (es)
AR (1) AR024981A1 (es)
AT (1) ATE314064T1 (es)
AU (1) AU779094B2 (es)
CA (1) CA2378724C (es)
CZ (1) CZ20024A3 (es)
DE (1) DE60025215T2 (es)
DK (1) DK1200077T3 (es)
ES (1) ES2254206T3 (es)
HU (1) HU229185B1 (es)
IL (1) IL147410A0 (es)
IT (1) IT1306179B1 (es)
MX (1) MXPA02000911A (es)
NO (1) NO20020369L (es)
PL (1) PL208961B1 (es)
SK (1) SK952002A3 (es)
TN (1) TNSN00163A1 (es)
TR (1) TR200200224T2 (es)
WO (1) WO2001007039A2 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7238531B2 (en) * 1999-01-30 2007-07-03 Pediatrix Screening, Inc. Method for interpreting tandem mass spectrometry data for clinical diagnosis
US7297545B2 (en) * 1999-01-30 2007-11-20 Pediatrix Screening, Inc. Clinical method for the genetic screening of newborns using tandem mass spectrometry and internal standards therefor
US7011977B2 (en) * 1999-01-30 2006-03-14 Sigma-Tau Pharmaceuticals, Inc. Quantification of carnitine levels in dialysis patients
IT1306179B1 (it) * 1999-07-28 2001-05-30 Sigma Tau Healthscience Spa Composizione per la prevenzione e cura delle disfunzioni e patologierenali di tipo tossico e funzionale.
US7709539B2 (en) * 2004-08-11 2010-05-04 Chang Gung University Therapeutic use of resveratrol for hyperglycemia
US20060153934A1 (en) * 2005-01-13 2006-07-13 Navitas Pharma Combination therapies of cicletanine and magnesium
US8492432B2 (en) 2005-08-17 2013-07-23 Hill's Pet Nutrition, Inc. Methods for the treatment of kidney disease
ES2385169B1 (es) * 2010-12-22 2013-09-23 Servicio Andaluz De Salud Uso de la l-carnitina y sus composiciones, para el tratamiento y la prevención del daño renal.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0514928T3 (da) * 1991-05-24 1997-10-20 Wakamoto Pharma Co Ltd Fremgangsmåde til diagnosticering af nyresygdomme ved påvisning af albuminfragmenter
IT1277147B1 (it) 1995-01-20 1997-11-04 Sigma Tau Ind Farmaceuti Uso della carnitina e i suoi derivati per ridurre gli effetti tossici della ciclosporina-a e di altri farmaci immunosoppressivi.
IT1291113B1 (it) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
IT1291127B1 (it) * 1997-04-01 1998-12-29 Sigma Tau Ind Farmaceuti Integratore alimentare per soggetti dediti ad intensa e prolungata attivita' fisica
IT1295408B1 (it) 1997-10-03 1999-05-12 Sigma Tau Ind Farmaceuti Associazione di l-carnitina e alcanoil l-carnitine per il trattamento dell'alcoolismo
IT1306179B1 (it) * 1999-07-28 2001-05-30 Sigma Tau Healthscience Spa Composizione per la prevenzione e cura delle disfunzioni e patologierenali di tipo tossico e funzionale.

Also Published As

Publication number Publication date
CA2378724C (en) 2008-10-14
US20040057994A1 (en) 2004-03-25
AR024981A1 (es) 2002-11-06
ATE314064T1 (de) 2006-01-15
ITRM990483A0 (it) 1999-07-28
DE60025215D1 (de) 2006-02-02
NO20020369D0 (no) 2002-01-23
TR200200224T2 (tr) 2002-08-21
HUP0202314A2 (en) 2002-10-28
SK952002A3 (en) 2002-06-04
EP1200077B1 (en) 2005-12-28
CZ20024A3 (cs) 2002-06-12
ITRM990483A1 (it) 2001-01-28
PL354412A1 (en) 2004-01-12
AU6469200A (en) 2001-02-13
CA2378724A1 (en) 2001-02-01
HU229185B1 (en) 2013-09-30
DE60025215T2 (de) 2006-07-13
TNSN00163A1 (fr) 2005-11-10
EP1200077A2 (en) 2002-05-02
MXPA02000911A (es) 2002-10-23
DK1200077T3 (da) 2006-04-24
PL208961B1 (pl) 2011-06-30
IT1306179B1 (it) 2001-05-30
WO2001007039A3 (en) 2001-03-29
IL147410A0 (en) 2002-08-14
WO2001007039A2 (en) 2001-02-01
US7585896B2 (en) 2009-09-08
ES2254206T3 (es) 2006-06-16
US6653349B1 (en) 2003-11-25
HUP0202314A3 (en) 2003-03-28
AU779094B2 (en) 2005-01-06

Similar Documents

Publication Publication Date Title
NO20024610D0 (no) Synergistiske metoder og blandinger for behandling av kreft
AU6147401A (en) Compositions and methods for the treatment of cancer
NO20014046D0 (no) Gabapentinderivater for forhindring og behandling av visceral smerte
MXPA02004770A (es) Composiciones terapeuticas y metodos para su uso.
IL158181A0 (en) N-acetylcysteine compositions and methods for the treatment and prevention of drug toxicity
KR100510795B1 (en) Compositions and Methods for the Treatment of Tumor
FI20011403A (fi) Menetelmä ja koostumukset vatsan sairauksien hoitoon
NO20014314L (no) Blandinger og metoder for behandling av stafylokokkisk infeksjon
DK1176964T3 (da) Brug af ET743 til behandling af cancer
NO20024486L (no) Forbedret behandling av neovaskularisering
NO20054346D0 (no) Sammensetninger og fremgangsmater for forebygging og behandling av endotoksinrelaterte sykdommer og tilstander
NO20024776D0 (no) Hydroksyfenyl-piperazinyl-metyl-benzamidderivater til behandling av smerte
NO20024777D0 (no) Kinolinyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte
NO20020369L (no) Sammensetninger for forebyggelse og behandling av nyredysfunksjoner og -sykdommer
IL155174A0 (en) Methods and compositions for the treatment of inflammatory diseases
PL368035A1 (en) Compositions and methods for the treatment of cancer
NO20030978L (no) Behandling av urindysfunksjon
DE50009813D1 (de) Kombinationpräparat zur behandlung von sexueller dysfunktion
EE200300057A (et) Koostis vähi profülaktikaks ja raviks
NO20013651D0 (no) Anvendelse av fosfororganiske forbindelser for profylaktisk og terapeutisk behandling av infeksjoner
AU8906201A (en) Methods and compositions for the treatment and prevention of sexual dysfunction
NO20026148D0 (no) Medisiner for forhindring og behandling av neurodegenerative sykdommer
NO20022101D0 (no) Peptider for behandling av erektil dysfunksjon
NO20022990D0 (no) Fremgangsmåte og sammensetning for behandling av smerte
IS6020A (is) S-nítrósóþíól til meðferðar við blóðrásartruflunum